Esketamine Optimized the Efficacy of Dexmedetomidine in Treating Sleep Disorders with Comorbid Depression.

Neuropsychiatr Dis Treat · 2025 · PMC12266076 · PMID 40673111

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach statistical significanceno p-value reported

In patients receiving dexmedetomidine monotherapy, MADRS scores showed a numerical decline during the first three days of treatment, though this reduction failed to reach statistical significance.

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.